A First-in-Human Study of QY211 Gel in Adult Subjects

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 23, 2024

Study Completion Date

October 23, 2024

Conditions

Atopic Dermatitis

Interventions

DRUG

0.1% QY211 Gel or placebo

QY211 Gel or placebo topical applied to skin

DRUG

0.3% QY211 Gel or placebo

QY211 Gel or placebo topical applied to skin

DRUG

0.8% QY211 Gel or placebo

QY211 Gel or placebo topical applied to skin

DRUG

1.5% QY211 Gel or placebo

QY211 Gel or placebo topical applied to skin

Trial Locations (1)

RECRUITING

Huashan Hospital Affiliated to Fudan University, Shanghai